Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04022343
Title Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

renal cell carcinoma

Therapies

Cabozantinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.